A Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and Epirubicin for Locally Advanced Breast Cancer

Jinsun Lee,Jeryong Kim,Eilsung Chang,Woonjung Choi,Kwang-Man Lee,Hyunjo Yoon,Sung-Hoo Jung,Minho Park,JungHan Yoon,Sung Yong Kim

A Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and Epirubicin for Locally Advanced Breast Cancer

2014

Jinsun Lee
Jeryong Kim
Eilsung Chang
Woonjung Choi
Kwang-Man Lee
Hyunjo Yoon
Sung-Hoo Jung
Minho Park
JungHan Yoon
Sung Yong Kim

Purpose Neoadjuvant chemotherapy (NC) is yet to be established as the definitive treatment regimen for locally advanced breast cancer (LABC). The aim of this study was to determine the efficacy and toxicity of NC with epirubicin and paclitaxel.

Keywords:

Regimen
Neoadjuvant therapy
Breast cancer
Paclitaxel
Epirubicin
Medicine
General surgery
Chemotherapy
Survival rate
Progressive disease
Neutropenia
Primary tumor
Oncology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations